![](/images/Email.png)
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Vertex Pharmaceuticals Incorporated
US Patent
Vertex Pharmaceuticals Incorporated
US Patent
Affinity DataKi: 6nM ΔG°: -46.9kJ/molepH: 7.5 T: 2°CAssay Description:Compounds were screened for their ability to inhibit ATR kinase using a radioactive-phosphate incorporation assay. Assays were carried out in a mixtu...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Vertex Pharmaceuticals Incorporated
US Patent
Vertex Pharmaceuticals Incorporated
US Patent
Affinity DataKi: 6nMAssay Description:Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrat...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Vertex Pharmaceuticals Incorporated
US Patent
Vertex Pharmaceuticals Incorporated
US Patent
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopi...More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)